US Bancorp DE Has $1.93 Million Stake in Henry Schein, Inc. $HSIC

US Bancorp DE lowered its position in Henry Schein, Inc. (NASDAQ:HSIC) by 26.9% during the second quarter, according to its most recent filing with the SEC. The firm owned 26,444 shares of the company’s stock after selling 9,718 shares during the period. US Bancorp DE’s holdings in Henry Schein were worth $1,932,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of HSIC. Rakuten Securities Inc. acquired a new position in shares of Henry Schein during the 1st quarter valued at $34,000. Steph & Co. acquired a new position in shares of Henry Schein during the 2nd quarter valued at $44,000. CX Institutional lifted its position in shares of Henry Schein by 107.3% during the 2nd quarter. CX Institutional now owns 651 shares of the company’s stock valued at $48,000 after acquiring an additional 337 shares during the period. TD Private Client Wealth LLC lifted its position in shares of Henry Schein by 103.0% during the 2nd quarter. TD Private Client Wealth LLC now owns 668 shares of the company’s stock valued at $49,000 after acquiring an additional 339 shares during the period. Finally, Whittier Trust Co. lifted its position in shares of Henry Schein by 714.3% during the 1st quarter. Whittier Trust Co. now owns 798 shares of the company’s stock valued at $55,000 after acquiring an additional 700 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

HSIC has been the topic of a number of research reports. Leerink Partners set a $75.00 target price on shares of Henry Schein in a research report on Monday, July 14th. Weiss Ratings reiterated a “hold (c)” rating on shares of Henry Schein in a research report on Wednesday, October 8th. Barrington Research restated an “outperform” rating and set a $78.00 price target on shares of Henry Schein in a research note on Tuesday, September 23rd. Stifel Nicolaus restated a “hold” rating and set a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Finally, Robert W. Baird restated a “neutral” rating and set a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Five research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, Henry Schein currently has an average rating of “Hold” and a consensus price target of $76.67.

Henry Schein Stock Performance

NASDAQ HSIC opened at $63.25 on Thursday. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The firm has a market cap of $7.67 billion, a price-to-earnings ratio of 20.40, a PEG ratio of 2.09 and a beta of 0.81. The company has a fifty day moving average price of $67.25 and a 200-day moving average price of $68.68.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). The firm had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business’s revenue was up 3.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.